Cognitive Effects of Hormonal Therapy in Older Adults

Seminars in Oncology

Volumn 35, Issue 6, 2008, Pages 569-581

  Mitsiades, Nicholas ^a   Correa, Denise ^a   Gross, Cary P ^b   Hurria, Arti ^c   Slovin, Susan F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Robert Wood Johnson Clinical Scholars Program   (United States)

^c Cancer and Aging Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROGEN; ESTRADIOL; ESTROGEN; GOSERELIN; TAMOXIFEN;

ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; BREAST CANCER; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DRUG EFFECT; HORMONAL THERAPY; HUMAN; MEMORY DISORDER; NEUROPROTECTION; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AGING; ALZHEIMER DISEASE; ANDROPAUSE; COGNITION DISORDERS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MENOPAUSE;

EID: 56549099684     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.08.002     Document Type: Article

References (90)

1. Janowsky J.S. Thinking with your gonads: testosterone and cognition. Trends Cogn Sci 10 (2006) 77-82
2. Jenkins V., Atkins L., and Fallowfield L. Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition?. Eur J Cancer 43 (2007) 1342-1347
3. Sherwin B.B. Estrogen and cognitive functioning in women. Endocr Rev 24 (2003) 133-151
4. McEwen B.S., and Alves S.E. Estrogen actions in the central nervous system. Endocr Rev 20 (1999) 279-307
5. Roselli C.E., Klosterman S.A., and Fasasi T.A. Sex differences in androgen responsiveness in the rat brain: regional differences in the induction of aromatase activity. Neuroendocrinology 64 (1996) 139-145
6. Chowen J.A., Torres-Aleman I., and Garcia-Segura L.M. Trophic effects of estradiol on fetal rat hypothalamic neurons. Neuroendocrinology 56 (1992) 895-901
7. Zaulyanov L.L., Green P.S., and Simpkins J.W. Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in vitro model for assessment of the neuroprotective effects of estrogens. Cell Mol Neurobiol 19 (1999) 705-718
8. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., and Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51 (1997) 535-541
9. Simpkins J.W., Rajakumar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J., et al. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 87 (1997) 724-730
10. Fugger H.N., Foster T.C., Gustafsson J., and Rissman E.F. Novel effects of estradiol and estrogen receptor alpha and beta on cognitive function. Brain Res 883 (2000) 258-264
11. McCullough L.D., Blizzard K., Simpson E.R., Oz O.K., and Hurn P.D. Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J Neurosci 23 (2003) 8701-8705
12. Azcoitia I., Sierra A., Veiga S., Honda S., Harada N., and Garcia-Segura L.M. Brain aromatase is neuroprotective. J Neurobiol 47 (2001) 318-329
13. Beyenburg S., Watzka M., Clusmann H., Blumcke I., Bidlingmaier F., Elger C.E., et al. Androgen receptor mRNA expression in the human hippocampus. Neurosci Lett 294 (2000) 25-28
14. Celotti F., Negri-Cesi P., and Poletti A. Steroid metabolism in the mammalian brain: 5alpha-reduction and aromatization. Brain Res Bull 44 (1997) 365-375
15. Hojo Y., Hattori T.A., Enami T., Furukawa A., Suzuki K., Ishii H.T., et al. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc Natl Acad Sci U S A 101 (2004) 865-870
16. Zwain I.H., and Yen S.S. Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 140 (1999) 880-887
17. Tirassa P., Thiblin I., Agren G., Vigneti E., Aloe L., and Stenfors C. High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J Neurosci Res 47 (1997) 198-207
18. Pouliot W.A., Handa R.J., and Beck S.G. Androgen modulates N-methyl-D-aspartate-mediated depolarization in CA1 hippocampal pyramidal cells. Synapse 23 (1996) 10-19
19. Ahlbom E., Prins G.S., and Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res 892 (2001) 255-262
20. Leranth C., Prange-Kiel J., Frick K.M., and Horvath T.L. Low CA1 spine synapse density is further reduced by castration in male non-human primates. Cereb Cortex 14 (2004) 503-510
21. Leranth C., Petnehazy O., and MacLusky N.J. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci 23 (2003) 1588-1592
22. Fuller S.J., Tan R.S., and Martins R.N. Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions. J Alzheimers Dis 12 (2007) 129-142
23. Gouras G.K., Xu H., Gross R.S., Greenfield J.P., Hai B., Wang R., et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci U S A 97 (2000) 1202-1205
24. Ramsden M., Nyborg A.C., Murphy M.P., Chang L., Stanczyk F.Z., and Golde T.E. Androgens modulate beta-amyloid levels in male rat brain. J Neurochem 87 (2003) 1052-1055
25. Pike C.J. Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res 919 (2001) 160-165
26. Goodenough S., Engert S., and Behl C. Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neurosci Lett 296 (2000) 49-52
27. Papasozomenos S.C. The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease. Proc Natl Acad Sci U S A 94 (1997) 6612-6617
28. Petanceska S.S., Nagy V., Frail D., and Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp Gerontol 35 (2000) 1317-1325 2000
29. Hogervorst E., Williams J., Budge M., Barnetson L., Combrinck M., and Smith A.D. Serum total testosterone is lower in men with Alzheimer's disease. Neuro Endocrinol Lett 22 (2001) 163-168
30. Moffat S.D., Zonderman A.B., Metter E.J., Kawas C., Blackman M.R., Harman S.M., et al. Free testosterone and risk for Alzheimer disease in older men. Neurology 62 (2004) 188-193
31. Hogervorst E., Bandelow S., Combrinck M., and Smith A.D. Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol 39 (2004) 1633-1639
32. Almeida O.P., Waterreus A., Spry N., Flicker L., and Martins R.N. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 29 (2004) 1071-1081
33. Lessov-Schlaggar C.N., Reed T., Swan G.E., Krasnow R.E., DeCarli C., Marcus R., et al. Association of sex steroid hormones with brain morphology and cognition in healthy elderly men. Neurology 65 (2005) 1591-1596
34. Geerlings M.I., Strozyk D., Masaki K., Remaley A.T., Petrovitch H., Ross G.W., et al. Endogenous sex hormones, cognitive decline, and future dementia in old men. Ann Neurol 60 (2006) 346-355
35. Rabbitt P., and Lowe C. Patterns of cognitive ageing. Psychol Res 63 (2000) 308-316
36. Sherwin B.B. The clinical relevance of the relationship between estrogen and cognition in women. J Steroid Biochem Mol Biol 106 (2007) 151-156
37. Maki P.M. Estrogen effects on the hippocampus and frontal lobes. Int J Fertil Womens Med 50 (2005) 67-71
38. LeBlanc E.S., Janowsky J., Chan B.K., and Nelson H.D. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285 (2001) 1489-1499
39. Haskell S.G., Richardson E.D., and Horwitz R.I. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J Clin Epidemiol 50 (1997) 1249-1264
40. Sherwin B.B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13 (1988) 345-357
41. Phillips S.M., and Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17 (1992) 485-495
42. Grady D., Yaffe K., Kristof M., Lin F., Richards C., and Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med 113 (2002) 543-548
43. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
44. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
45. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (2004) 1701-1712
46. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 2947-2958
47. Duka T., Tasker R., and McGowan J.F. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology (Berl) 149 (2000) 129-139
48. Sherwin B.B. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?. J Neuroendocrinol 19 (2007) 77-81
49. Adams M.M., Shah R.A., Janssen W.G., and Morrison J.H. Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. Proc Natl Acad Sci U S A 98 (2001) 8071-8076
50. Gibbs R.B. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 21 (2000) 107-116
51. Jezierski M.K., and Sohrabji F. Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol Aging 22 (2001) 309-319
52. Matthews K., Cauley J., Yaffe K., and Zmuda J.M. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 47 (1999) 518-523
53. MacLennan A.H., Henderson V.W., Paine B.J., Mathias J., Ramsay E.N., Ryan P., et al. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 13 (2006) 28-36
54. Henderson V.W., Guthrie J.R., Dudley E.C., Burger H.G., and Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60 (2003) 1369-1371
55. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 138 (2006) 1027-1030
56. Eberling J.L., Wu C., Tong-Turnbeaugh R., and Jagust W.J. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage 21 (2004) 364-371
57. Paganini-Hill A., and Clark L.J. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64 (2000) 165-176
58. Bender C.M., Sereika S.M., Berga S.L., Vogel V.G., Brufsky A.M., Paraska K.K., et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15 (2006) 422-430
59. Baum M., Budzar A.U., Cuzick J., Forbes J., Houghton J.H., Klijn J.G., et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359 (2002) 2131-2139
60. Jenkins V., Shilling V., Fallowfield L., Howell A., and Hutton S. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition?. A pilot study. Psychooncology 13 (2004) 61-66
61. Shilling V., Jenkins V., Fallowfield L., and Howell T. The effects of hormone therapy on cognition in breast cancer. J Steroid Biochem Mol Biol 86 (2003) 405-412
62. Bender C.M., Sereika S.M., Brufsky A.M., Ryan C.M., Vogel V.G., Rastogi P., et al. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 14 (2007) 995-998
63. Juul A., and Skakkebaek N.E. Androgens and the ageing male. Hum Reprod Update 8 (2002) 423-433
64. Kaufman J.M., and Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26 (2005) 833-876
65. Lamberts S.W., van den Beld A.W., and van der Lely A.J. The endocrinology of aging. Science 278 (1997) 419-424
66. Harman S.M., Metter E.J., Tobin J.D., Pearson J., and Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86 (2001) 724-731
67. Moffat S.D., Zonderman A.B., Metter E.J., Blackman M.R., Harman S.M., and Resnick S.M. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 87 (2002) 5001-5007
68. Yaffe K., Lui L.Y., Zmuda J., and Cauley J. Sex hormones and cognitive function in older men. J Am Geriatr Soc 50 (2002) 707-712
69. Fonda S.J., Bertrand R., O'Donnell A., Longcope C., and McKinlay J.B. Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci 60 (2005) 385-390
70. Cherrier M.M., Asthana S., Plymate S., Baker L., Matsumoto A.M., Peskind E., et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 57 (2001) 80-88
71. Cherrier M.M., Matsumoto A.M., Amory J.K., Ahmed S., Bremner W., Peskind E.R., et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology 64 (2005) 290-296
72. Janowsky J.S., Chavez B., and Orwoll E. Sex steroids modify working memory. J Cogn Neurosci 12 (2000) 407-414
73. Janowsky J.S., Oviatt S.K., and Orwoll E.S. Testosterone influences spatial cognition in older men. Behav Neurosci 108 (1994) 325-332
74. Barrett-Connor E., Goodman-Gruen D., and Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 84 (1999) 3681-3685
75. Moffat S.D., and Hampson E. A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference. Psychoneuroendocrinology 21 (1996) 323-337
76. Muller M., Aleman A., Grobbee D.E., de Haan E.H., and van der Schouw Y.T. Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level?. Neurology 64 (2005) 866-871
77. Sih R., Morley J.E., Kaiser F.E., Perry III H.M., Patrick P., and Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82 (1997) 1661-1667
78. Kenny A.M., Bellantonio S., Gruman C.A., Acosta R.D., and Prestwood K.M. Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 57 (2002) M321-M325
79. Emmelot-Vonk M.H., Verhaar H.J., Nakhai Pour H.R., Aleman A., Lock T.M., Bosch J.L., et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 299 (2008) 39-52
80. Vaughan C., Goldstein F.C., and Tenover J.L. Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone. J Androl 28 (2007) 875-882
81. Alibhai S.M., Gogov S., and Allibhai Z. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 60 (2006) 201-215
82. Jenkins V.A., Bloomfield D.J., Shilling V.M., and Edginton T.L. Does neoadjuvant hormone therapy for early prostate cancer affect cognition?. Results from a pilot study. BJU Int 96 (2005) 48-53
83. Salminen E.K., Portin R.I., Koskinen A., Helenius H., and Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res 10 (2004) 7575-7582
84. Salminen E., Portin R., Korpela J., Backman H., Parvinen L.M., Helenius H., et al. Androgen deprivation and cognition in prostate cancer. Br J Cancer 89 (2003) 971-976
85. Cherrier M.M., Rose A.L., and Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol 170 (2003) 1808-1811
86. Green H.J., Pakenham K.I., Headley B.C., Yaxley J., Nicol D.L., Mactaggart P.N., et al. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 90 (2002) 427-432
87. Green H.J., Pakenham K.I., Headley B.C., Yaxley J., Nicol D.L., Mactaggart P.N., et al. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int 93 (2004) 975-979
88. Joly F., Alibhai S.M., Galica J., Park A., Yi Q.L., Wagner L., et al. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol 176 (2006) 2443-2447
89. Taxel P., Stevens M.C., Trahiotis M., Zimmerman J., and Kaplan R.F. The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer. J Am Geriatr Soc 52 (2004) 269-273
90. Vardy J., Wefel J.S., Ahles T., Tannock I.F., and Schagen S.B. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19 (2008) 623-629